Gibson Dunn announced today that Margaux J. Hall has joined the firm as a partner in its FDA and Health Care and Life Sciences Practice Groups in Washington, D.C.  Margaux is a leading health regulatory lawyer who advises pharmaceutical manufacturers, investors, and other entities in the supply chain on drug pricing, market access, and value-based arrangements. The post Gibson Dunn Expands Drug Pricing and Market Access Capabilities With Preeminent Health Regulatory Lawyer Margaux Hall appeared